Announced Fri, 21 Aug · 16:51 IST

Oxygenta Pharma 33rd AGM: All 7 resolutions approved

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.6%1-day move
₹63.85
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-7.6-5.1-6.8-9.9-13.0-13.9-16.4
Up moveDown movePending
AI summary

Oxygenta Pharmaceutical Limited held its 33rd AGM on 21 August 2026 via video conferencing. All 7 resolutions were approved with requisite majority. Only 12.09 percent of outstanding shares were polled. Items covered: adoption of FY26 audited financials, reappointment of Mr. Balasubba Reddy Mamilla, appointment of Mr. Amireddy Venkatesu Reddy as Whole-time Director, appointment of Mr. Janardhana Reddy Yeddula as Independent Director, two material related party transactions with holding company Virupaksha Organics Limited, and ratification of cost auditor remuneration.

Likely market impact

Routine AGM clearance with all resolutions passing. New WTD and Independent Director appointed; related party transactions with holding firm approved. Low 12 percent voting turnout is normal.